Respiratory Intensive Care

We were delighted to speak with our editorial board member Professor Margaret Pisani (Yale University School of Medicine, New Haven, CT, USA) around this year’s research highlights in pulmonary, critical care and sleep medicine and what to look out for in 2022. Questions What are the key clinical highlights from 2021 in the field of […]

It was a pleasure to meet with Dr Wayne Anderson (UNC School of Medicine, Chapel Hill, NC, US) to discuss his recent study evaluating the safety and tolerability of BIO­‑11006 in patients with acute respiratory distress syndrome. ‘A Phase II, Placebo‑Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO­‑11006 Inhalation Solution in […]

It was a pleasure to meet with Dr Wayne Anderson (UNC School of Medicine, Chapel Hill, NC, US) to discuss his recent study evaluating the safety and tolerability of BIO­‑11006 in patients with acute respiratory distress syndrome. ‘A Phase II, Placebo‑Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO­‑11006 Inhalation Solution in […]

Benjamin Seeliger, Hannover, Germany, spoke to us at ERS 2019 in Madrid about the EOLIA trial and ECMO in veno-venous extracorporeal membrane oxygenation therapy. Questions 1. What is known about the effectiveness of extracorporeal membrane oxygenation (ECMO) in respiratory failure? (0:05) 2. What are the major challenges in designing clinical trials to investigate the utility […]

At the 2019 ATS conference in Dallas, TX, USA, Jacqueline Kruser (Northwestern University, Chicago, IL, USA) discusses the knowledge gap in end-of-life (EOL) care and the implications of her study findings in terms of meeting unmet needs in EOL care in patients in the ICU. Questions 1. What is currently known about end-of-life (EOL) care […]

Margaret Pisani (Yale University School of Medicine, New Haven, CT, USA) speaks from the 2019 ATS conference in Dallas, TX, USA about the impact of delirium in the intensive care unit (ICU) and new evidence on the potential benefits of pharmacological interventions to manage delirium. She also discusses the unmet needs for ICU patients with […]

Mark L Metersky (University of Connecticut School of Medicine, Farmington, CT, US) discusses current recommendations and guidelines with respect to the use of empiric antibiotic therapy in patients with ventilator-associated pneumonia. Questions 1. What are the major challenges of empiric antibiotic therapy in patients with ventilator-associated pneumonia? (0:10) 2. How are patients defined in terms […]